Pharmaceutical company “Yuria-Pharm” is considering the possibility of supplying anti-TB drugs in Brazil, said the General Director of LLC “Yuriya-farm” Dmitry Derkach.

Currently, the company expects the results of the inspection of production sites conducted by the regulatory authority of Brazil, the National Agency for supervision in the sphere of health of Brazil (Agencia Nacional deVigilancia Sanitaria, ANVISA), he said during a press conference in Agency “Interfax-Ukraine.

“Brazil today is interested in the production company “Yuria-Pharm”, in particular, is anti-TB drugs,” said D. Derkach.

The company plans to continue in 2018, work on the introduction of production of new medicines, the implementation of the strategy for entering international markets.

“Today our products are represented in more than 25 countries around the world. In General, the work is conducted in 50 countries,” he said .

According to the company “Business Credit”, in the first 11 months of “Yuria-Pharm” entered the top three leaders by volume of pharmacy’s sales in real terms and is a dynamic leader in high-price cluster.

As reported, the manufacturer of infusion solutions, medicines and products of medical appointment “Yuri-farm” by the end of 2016 entered the top ten on the volume of pharmacy sales, occupying 6.2 percent of the market.

“Yuria-Pharm” is a member of the Association “Manufacturers of drugs of Ukraine” (APLU).